1. Home
  2. PTCT vs BRZE Comparison

PTCT vs BRZE Comparison

Compare PTCT & BRZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • BRZE
  • Stock Information
  • Founded
  • PTCT 1998
  • BRZE 2011
  • Country
  • PTCT United States
  • BRZE United States
  • Employees
  • PTCT N/A
  • BRZE N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • BRZE Computer Software: Prepackaged Software
  • Sector
  • PTCT Health Care
  • BRZE Technology
  • Exchange
  • PTCT Nasdaq
  • BRZE Nasdaq
  • Market Cap
  • PTCT 5.3B
  • BRZE 3.1B
  • IPO Year
  • PTCT 2013
  • BRZE 2021
  • Fundamental
  • Price
  • PTCT $73.68
  • BRZE $28.65
  • Analyst Decision
  • PTCT Buy
  • BRZE Strong Buy
  • Analyst Count
  • PTCT 17
  • BRZE 20
  • Target Price
  • PTCT $73.24
  • BRZE $44.65
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • BRZE 1.3M
  • Earning Date
  • PTCT 11-04-2025
  • BRZE 12-08-2025
  • Dividend Yield
  • PTCT N/A
  • BRZE N/A
  • EPS Growth
  • PTCT N/A
  • BRZE N/A
  • EPS
  • PTCT 8.94
  • BRZE N/A
  • Revenue
  • PTCT $1,779,150,000.00
  • BRZE $654,622,000.00
  • Revenue This Year
  • PTCT $119.02
  • BRZE $23.36
  • Revenue Next Year
  • PTCT N/A
  • BRZE $17.31
  • P/E Ratio
  • PTCT $8.24
  • BRZE N/A
  • Revenue Growth
  • PTCT 97.54
  • BRZE 22.16
  • 52 Week Low
  • PTCT $35.95
  • BRZE $23.91
  • 52 Week High
  • PTCT $73.99
  • BRZE $48.33
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 76.24
  • BRZE 54.04
  • Support Level
  • PTCT $69.23
  • BRZE $26.23
  • Resistance Level
  • PTCT $73.98
  • BRZE $28.64
  • Average True Range (ATR)
  • PTCT 2.61
  • BRZE 1.17
  • MACD
  • PTCT 0.26
  • BRZE 0.14
  • Stochastic Oscillator
  • PTCT 95.68
  • BRZE 85.09

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.

Share on Social Networks: